Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Change in Receivables (2022)

SELLAS Life Sciences (SLS) has disclosed Change in Receivables for 1 consecutive years, with $1.0 million as the latest value for Q1 2022.

  • On a quarterly basis, Change in Receivables changed N/A to $1.0 million in Q1 2022 year-over-year; TTM through Mar 2023 was $1.0 million, a 0.0% change, with the full-year FY2014 number at -$1.6 million, down 144.64% from a year prior.
  • Change in Receivables was $1.0 million for Q1 2022 at SELLAS Life Sciences.
  • In the past five years, Change in Receivables ranged from a high of $1.0 million in Q1 2022 to a low of $1.0 million in Q1 2022.